Sensei Biotherapeutics Valuation
| SNSE Stock | USD 0.49 0.03 6.52% |
Sensei Biotherapeutics is undervalued. Sensei Biotherapeutics has a current Real Value of $1.4 per share. The regular price of the company is $0.49. Our model measures the value of Sensei Biotherapeutics from inspecting the company fundamentals such as Return On Equity of -0.51, shares outstanding of 25.15 M, and Shares Owned By Institutions of 9.37 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Sensei Biotherapeutics' valuation include:
Undervalued
Today
Please note that Sensei Biotherapeutics' price fluctuation is very risky at this time. Calculation of the real value of Sensei Biotherapeutics is based on 3 months time horizon. Increasing Sensei Biotherapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sensei stock is determined by what a typical buyer is willing to pay for full or partial control of Sensei Biotherapeutics. Since Sensei Biotherapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sensei Stock. However, Sensei Biotherapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.49 | Real 1.4 | Target 4.13 | Hype 0.49 | Naive 0.51 |
The real value of Sensei Stock, also known as its intrinsic value, is the underlying worth of Sensei Biotherapeutics Company, which is reflected in its stock price. It is based on Sensei Biotherapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sensei Biotherapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sensei Biotherapeutics helps investors to forecast how Sensei stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sensei Biotherapeutics more accurately as focusing exclusively on Sensei Biotherapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Sensei Biotherapeutics' intrinsic value based on its ongoing forecasts of Sensei Biotherapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Sensei Biotherapeutics' closest peers. If more than one evaluation category is relevant for Sensei Biotherapeutics we suggest using both methods to arrive at a better estimate.
Sensei Biotherapeutics Cash |
|
Sensei Valuation Trend
Comparing Sensei Biotherapeutics' enterprise value against its market capitalization is a good way to estimate the value of Sensei Biotherapeutics uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Sensei Biotherapeutics Total Value Analysis
Sensei Biotherapeutics is at this time projected to have valuation of (30.21 M) with market capitalization of 12.32 M, debt of 6.21 M, and cash on hands of 123.71 M. The negative valuation of Sensei Biotherapeutics may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Sensei Biotherapeutics fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(30.21 M) | 12.32 M | 6.21 M | 123.71 M |
Sensei Biotherapeutics Asset Utilization
One of the ways to look at asset utilization of Sensei is to check how much profit was generated for every dollar of assets it reports. Sensei Biotherapeutics has a negative utilization of assets of -0.3 %, losing $0.003019 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Sensei Biotherapeutics shows how discouraging it operates for each dollar spent on its assets.Sensei Biotherapeutics Ownership Allocation
Sensei Biotherapeutics shows a total of 25.15 Million outstanding shares. Sensei Biotherapeutics maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sensei Biotherapeutics Profitability Analysis
Net Loss for the year was (34.1 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sensei Biotherapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sensei Biotherapeutics and how it compares across the competition.
About Sensei Biotherapeutics Valuation
The stock valuation mechanism determines Sensei Biotherapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Sensei Biotherapeutics. We calculate exposure to Sensei Biotherapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sensei Biotherapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -513.9 K | -539.6 K |
Sensei Biotherapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Sensei Biotherapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 28 M |
Sensei Biotherapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Sensei Biotherapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Sensei we look at many different elements of the entity such as Sensei's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Sensei Biotherapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Sensei Biotherapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Sensei Biotherapeutics' worth.Complementary Tools for Sensei Stock analysis
When running Sensei Biotherapeutics' price analysis, check to measure Sensei Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensei Biotherapeutics is operating at the current time. Most of Sensei Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Sensei Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensei Biotherapeutics' price. Additionally, you may evaluate how the addition of Sensei Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |